🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

15+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 15 of 15 recruiting trials for “Hemophilia A”

Phase 4RecruitingNCT05936580 ↗

Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery

👨‍⚕️ Johannes Oldenburg, Experimental Haematology and Transfusion Medicine, University Clinic Bonn📍 15 sites📅 Started Apr 2026View details ↗
Phase 4RecruitingNCT06864975 ↗

Assessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys with Inhibitor (INITIATE Study)

🏥 Runhui WU📍 1 site📅 Started Mar 2025View details ↗
Phase 1RecruitingNCT06579144 ↗

Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia A

👨‍⚕️ Elena Santagostino, MD, Sobi AB📍 8 sites📅 Started Feb 2025View details ↗
Phase 3RecruitingNCT06738485 ↗

Recombinant Single-chain Factor VIII (rVIII-SingleChain) in Chinese Participants With Hemophilia A Previously Treated With FVIII Products

👨‍⚕️ Study Director, CSL Behring📍 20 sites📅 Started Jan 2025View details ↗
RecruitingNCT06684314 ↗

A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A in Taiwan

🏥 Sanofi📍 10 sites📅 Started Nov 2024View details ↗
RecruitingNCT07414511 ↗

Hemophilia A Research Program

👨‍⚕️ Jill M Johnsen, MD, University of Washington📍 1 site📅 Started Jul 2024View details ↗
EARLY_Phase 1RecruitingNCT06345833 ↗

Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded Study

👨‍⚕️ Jenna Van Beck, MD, University of Minnesota📍 1 site📅 Started Jul 2024View details ↗
RecruitingNCT06352216 ↗

Prevalence of Synovitis in Patients With Haemophilia A

👨‍⚕️ Andreas C Strauss, PD Dr. med., University Hospital, Bonn📍 1 site📅 Started Apr 2024View details ↗
NARecruitingNCT05629130 ↗

Embolization in Hereditary Coagulopathies

👨‍⚕️ Fabiane E FArias, PT, IOT-HC-FMUSP (Orthopedics Institute - General Hospital- School of Medicine - University of Sao Paulo📍 1 site📅 Started Jan 2023View details ↗
Phase 3RecruitingNCT05611801 ↗

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

👨‍⚕️ Pfizer CT.gov Call Center, Pfizer📍 66 sites📅 Started Dec 2022View details ↗
Phase 4RecruitingNCT06320626 ↗

Pharmacokinetic-guided Dosing of Emicizumab

👨‍⚕️ Study Officials Fischer, Dr, MD, UMC Utrecht📍 8 sites📅 Started Sep 2022View details ↗
Phase 4RecruitingNCT04567511 ↗

Hemlibra in Mild Hemophilia A

👨‍⚕️ Amy D Shapiro, MD, Indiana Hemophilia &Thrombosis Center, Inc.📍 1 site📅 Started Jul 2022View details ↗
EARLY_Phase 1RecruitingNCT05454774 ↗

A Study of FVIII Gene Therapy for Hemophilia A

👨‍⚕️ Lei Zhang, MD, Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College📍 1 site📅 Started Jul 2022View details ↗
RecruitingNCT04023019 ↗

Treatment of Hemophilia A Patients With FVIII Inhibitors

👨‍⚕️ Robert Sidonio, MD, MSc, Emory University📍 2 sites📅 Started Mar 2020View details ↗
RecruitingNCT04131036 ↗

Effects of Emicizumab vs. Factor VIII Prophylaxis on Joint and Bone Health in Severe Hemophilia A

👨‍⚕️ Rebecca Kruse-Jarres, MD, MPH, Washington Institute for Coagulation📍 4 sites📅 Started Apr 2019View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →